Should You Buy USA Rare Earth While It's Below $20?

USA Rare Earth is positioned as a strategic U.S. rare-earth and magnet supplier, with a Texas deposit rich in terbium and dysprosium and plans to open a magnet factory in 2026 and a mine in 2028. The company has attracted about $3.1 billion in public and private funding, while a pending $1.6 billion funding package underscores government interest amid war-related supply concerns and China export restrictions. Shares still trade about 45% below their 52-week high, though the article frames the stock as highly speculative despite an implied ~70% upside to the $32 average target.

Analysis

USAR is a classic “optionality with duration” setup: the market is paying mostly for geopolitical insurance today, while the real equity value depends on execution milestones that sit 12-36 months out. That creates a wide gap between narrative momentum and fundamental cash generation, and it also means the stock can re-rate hard on any evidence of process de-risking long before first commercial production. The key second-order effect is that scarcity value in heavy rare earths can get monetized faster through offtake, strategic equity, or government-linked financing than through mine economics alone.

The more interesting competitive dynamic is not USAR versus MP on headline market cap, but USAR’s exposure to the most militarily sensitive inputs in the magnet supply chain. If supply security becomes the dominant procurement criterion, the value pool shifts from unit cost to assured domestic availability, which should support premium pricing, funding intensity, and potentially pre-buy commitments from defense-adjacent end users. That is bullish for the entire U.S. supply chain, but especially for processors, magnet makers, and capital providers who can sit upstream of production risk.

The contrarian risk is that the market is over-assigning near-term scarcity to a project that still has multiple execution gates. Any slippage in the magnet plant ramp or mine timeline likely compresses the multiple quickly because the stock’s current value is dominated by expectation, not earnings. Over the next few months, the main catalyst is not volume production but financing clarity, permitting progress, and evidence that the company can convert strategic relevance into binding contracts rather than headlines.

Key Decisions for Investors

• Go long MP over USAR as the lower-risk expression of the same thematic: MP has nearer-term revenue visibility and should capture any sector multiple expansion first; use a 3-6 month horizon and expect USAR to lag until execution is proven.
• Initiate a small starter long in USAR only on weakness, not strength, sized as a high-volatility catalyst trade; target a 20-30% upside re-rating on financing/permitting news, with a hard stop on any material schedule slip.
• Pair trade: long MP / short a basket of non-operating rare-earth developers to express ‘cash flow plus strategic scarcity’ versus ‘pure story’; this should reduce commodity beta while keeping geopolitical upside.
• For options, consider USAR call spreads 6-12 months out to cap premium bleed; the trade works only if one or two milestones land, and defined-risk structure is preferable given binary execution risk.
• Monitor defense procurement and funding announcements as the real catalyst window; if USAR secures a binding offtake or government-backed financing, reassess for a higher-conviction long because that converts strategic value into bankable demand.